These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36597979)

  • 1. Impact of rheumatoid arthritis and methotrexate on pregnancy outcomes: retrospective cohort study of the Italian Society for Rheumatology.
    Zanetti A; Zambon A; Scirè CA; Bortoluzzi A
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).
    Martínez Lopez JA; Loza E; Carmona L
    Clin Exp Rheumatol; 2009; 27(4):678-84. PubMed ID: 19772806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study.
    Weber-Schoendorfer C; Hoeltzenbein M; Wacker E; Meister R; Schaefer C
    Rheumatology (Oxford); 2014 Apr; 53(4):757-63. PubMed ID: 24369411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
    Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
    BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes in patients with rheumatoid arthritis who discontinue methotrexate treatment to conceive.
    Nagafuchi H; Goto Y; Kiyokawa T; Ooka S; Kawahata K
    Clin Rheumatol; 2022 Mar; 41(3):669-675. PubMed ID: 34778939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study.
    Weber-Schoendorfer C; Chambers C; Wacker E; Beghin D; Bernard N; ; Shechtman S; Johnson D; Cuppers-Maarschalkerweerd B; Pistelli A; Clementi M; Winterfeld U; Eleftheriou G; Pupco A; Kao K; Malm H; Elefant E; Koren G; Vial T; Ornoy A; Meister R; Schaefer C
    Arthritis Rheumatol; 2014 May; 66(5):1101-10. PubMed ID: 24470106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes.
    Chakravarty EF; Sanchez-Yamamoto D; Bush TM
    J Rheumatol; 2003 Feb; 30(2):241-6. PubMed ID: 12563675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for treating rheumatoid arthritis.
    Lopez-Olivo MA; Siddhanamatha HR; Shea B; Tugwell P; Wells GA; Suarez-Almazor ME
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD000957. PubMed ID: 24916606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
    Shimizu Y; Nakajima A; Inoue E; Shidara K; Sugimoto N; Seto Y; Tanaka E; Momohara S; Taniguchi A; Yamanaka H
    Clin Rheumatol; 2017 Jun; 36(6):1237-1245. PubMed ID: 28455827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label observation of addition of etanercept versus a conventional disease-modifying antirheumatic drug in subjects with active rheumatoid arthritis despite methotrexate therapy in the Latin American region.
    Machado DA; Guzman RM; Xavier RM; Simon JA; Mele L; Pedersen R; Ferdousi T; Koenig AS; Kotak S; Vlahos B
    J Clin Rheumatol; 2014 Jan; 20(1):25-33. PubMed ID: 24356474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial methotrexate dosage is not associated with an increased risk of liver toxicity in patients with rheumatoid arthritis.
    Choi SR; Park JW; Lee EB; Park JK
    Clin Rheumatol; 2021 Nov; 40(11):4493-4500. PubMed ID: 34115231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB; von Kempis J; Haile SR; Schiff MH
    Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations Between Methotrexate Use and the Risk of Cardiovascular Events in Patients with Elderly-onset Rheumatoid Arthritis.
    Widdifield J; Abrahamowicz M; Paterson JM; Huang A; Thorne JC; Pope JE; Kuriya B; Beauchamp ME; Bernatsky S
    J Rheumatol; 2019 May; 46(5):467-474. PubMed ID: 30504508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort.
    Gaujoux-Viala C; Rincheval N; Dougados M; Combe B; Fautrel B
    Ann Rheum Dis; 2017 Dec; 76(12):2054-2060. PubMed ID: 28866645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate.
    Hilal G; Akasbi N; Boudouaya H; Salma K; Harzy T
    Curr Rheumatol Rev; 2020; 16(4):293-297. PubMed ID: 32189595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.
    de Thurah A; Nørgaard M; Johansen M; Stengaard-Pedersen K
    Scand J Rheumatol; 2010; 39(1):19-25. PubMed ID: 20132066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
    Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.